News in the Life Sciences Industry

OSLO, Norway, Nov. 7, 2019 /PRNewswire/ -- Photocure ASA (OSE: PHO), today reported a revenue growth of 42% in local currency for the U.S. market in the third quarter of 2019, contributing to Hexvix/Cysview revenues of NOK 51.1 million (Q3 2018: NOK 43.5) and an EBITDA of NOK 8.3 million (NOK... Read more ››

OSLO, Norway, Nov. 7, 2019 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its third quarter 2019 results.

BERGEN, Norway, Nov. 7, 2019 /PRNewswire/ -- BerGenBio ASA (OSE:BGBIO), will announce its results for the third quarter on Tuesday 19 November 2019. A presentation by BerGenBio's senior management team will take place at 10am CET at:

STOCKHOLM, Nov. 7, 2019 /PRNewswire/ --

STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of... Read more ››

STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- Ahlstrom-Munksjö announces the launch of TrustShield(TM), a versatile portfolio of medical fabrics that can be used to provide protection against surgical lasers, chemicals and potent chemotherapy drugs.

LUND, Sweden, Nov. 6, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the company will present new preclinical data showing that their drug candidate ATOR-1017 can induce a long-lasting immunological memory which is of great importance in a potential... Read more ››

STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that data from the clinical program evaluating its lead candidate melflufen in multiple myeloma and Light Chain (AL) Amyloidosis have been selected for six poster presentations to be featured... Read more ››